Why it matters
Insmed posted a GAAP EPS of -$0.06, beating the -$0.68 consensus by $0.62 (+91.2%). Revenue surged 296.1% YoY to $426M. The company issued FY2026 revenue guidance of $1.2B-$1.4B. — impact context not separately stored; see What changed.